Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Enzyme logo — A QMS as innovative as you

Enzyme

A QMS as innovative as you

Founded 2017 United States South San Francisco, United States 27 employees Seed Total: $1.97M Internet, Life Sciences +2

General Information

Company Name Enzyme
Founded Year 2017
Location United States South San Francisco, United States
Employees 27
Industries Internet, Life Sciences, Medical Devices +1
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Enzyme. To contact Enzyme, visit enzyme.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Enzyme compare?

A PDF of Enzyme and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Enzyme soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Enzyme

Enzyme, with a slogan of "A QMS as innovative as you," was founded in 2016 in the United States and has received a significant amount of funding, with its last investment being a $1.85M Seed Round on the 10th of October, 2017. The investment was led by an impressive group of investors including Soma Capital, DCVC, Refactor Capital, Hack VC, Rock Health Capital, Parcel B, Brad Flora, Kevin Moore, Danielle Morrill, and Elizabeth Iorns. Enzyme's mission is to automate and simplify life science regulatory approval and compliance, reducing the cost of compliance and accelerating the entry of cutting-edge technology to market. The company's cloud-based Quality Management System (QMS) streamlines documentation and seamlessly integrates with existing tools. Additionally, Enzyme provides expert guidance throughout the regulatory and compliance lifecycle, from pre-submission to post-market compliance. Enzyme caters to a wide range of life science companies, emphasizing its support for those involved in digital health and software as a medical device (SaMD) products. The company operates in the Internet and SaaS industries, offering innovative solutions tailored to the specific needs of the life science sector.

Business keywords: Quality Management System, Cloud-based software, Regulatory approval, Life science industry, Digital health, Software as a Medical Device (SaMD), FDA approval, Documentation management, Regulatory submission, Post-market compliance, Cost reduction, Consultant reduction, Product development, Regulatory lifecycle

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.85M 10
Soma Capital DCVC Refactor Capital
Soma Capital, DCVC +8
10 Oct 2017
Pre Seed Round $120.00K -
21 Aug 2017
Angel Round Undisclosed -
10 Jan 2017

Latest News

View All
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say  — Cnbc
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say 
Cnbc Aug 25, 2026

Enzyme Alternatives & Competitors

View All Alternatives
Enzyme vs
MethodSense, Inc.
MethodSense, Inc. United States

Regulatory and quality system professionals

12 employees
Life Sciences, Medical Devices
Enzyme vs
Qualio
Qualio United States

Scalable, fast, and trusted eQMS software to make quality easy.

Series B
116 employees
Biotechnology, Health and Wellness
Enzyme vs
Dot Compliance
Dot Compliance United States

Harness the power of AI for life sciences quality and compliance

Series B
188 employees
Cloud Infrastructure, Information Technology
Compare Enzyme vs Dot Compliance
View all alternatives

FAQ About Enzyme

A QMS as innovative as you
Enzyme was founded in 2017.
Enzyme is headquartered in South San Francisco, United States.
Enzyme operates in Internet, Life Sciences, Medical Devices and SaaS. Its work centres on Quality Management System, Cloud-based software, Regulatory approval and Life science industry.
Enzyme has approximately 27 employees.
Enzyme has completed 3 funding rounds, raising a total of $1.97M. The latest funding stage is Seed.
Top alternatives and competitors to Enzyme include MethodSense, Inc., Qualio, Dot Compliance, Invio, Inc., MediSpend. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Enzyme and MethodSense, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Enzyme, https://bouncewatch.com/company/enzyme, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes